| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V122037 | (Rac)-RG108 | 32675-71-1 | (Rac)-RG108 is a DNMT1 inhibitor that inhibits DNA methyltransferase. |
|
V0404 | Azacitidine (Ladakamycin; 5-AzaC) | 320-67-2 | 5-Azacytidine (5AzaC; Ladakamycin; U-18496; Vidaza;Mylosar;5-AzaC) is an FDA approved anticancer drug bearing a pyrimidine nucleoside core and belongs to cytosine class of antimetabolites. |
|
V75480 | HaeIII Methyltransferase (HaeIII) | 92228-40-5 | HaeIII Methyltransferase (HaeIII) is a methyltransferase that covalently binds to DNA. |
|
V86140 | HpaII Methyltransferase (HpaII ) | 85537-81-1 | |
|
V110766 | MGMT-IN-1 | MGMT-IN-1 (compound 2) is a photoactivated MGMT inhibitor. | |
|
V141717 | NV914 | 2341941-41-9 | NV914 is an FTSJ1 (tryptophan tRNA-specific 2'-O-methyltransferase) inhibitor. It inhibits the methyltransferase activity of FTSJ1, induces premature reading of the stop codon, and enables genes carrying nonsense mutations to synthesize full-length proteins. |
|
V0405 | RG-108 | 48208-26-0 | RG108, also known asN-Phthalyl-L-tryptophan,is a novel non-nucleoside inhibitor of DNA methyltransferase ((DNMT)with potential antitumor activity. |
|
V0408 | SGI-1027 | 1020149-73-8 | SGI-1027 is a novel and potent inhibitorof DNA methyltransferase (DNMT) with antineoplastic activity. |
|
V0409 | Lomeguatrib (PaTrin2) | 192441-08-0 | Lomeguatrib (formerly PaTrin-2) is a novel, potentand selective inhibitor of MGMT (O6-alkylguanine-DNA-alkyltransferase) with anticancer activity. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
